Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Tumor infiltrating lymphocytes
Therapeutic Area : Oncology
Study Phase : Undisclosed
Sponsor : Orgenesis
Deal Size : Undisclosed
Deal Type : Collaboration
Details : Clinical study will be undertaken with goal of utilizing and validating a number of Orgenesis’ proprietary POCare Technologies, including an automated cell culturing system for the generation and expansion tumor infiltrating lymphocytes for use in adop...
Brand Name : Undisclosed
Molecule Type : Cell and Gene therapy
Upfront Cash : Undisclosed
June 01, 2020
Lead Product(s) : Tumor infiltrating lymphocytes
Therapeutic Area : Oncology
Highest Development Status : Undisclosed
Sponsor : Orgenesis
Deal Size : Undisclosed
Deal Type : Collaboration
LOOKING FOR A SUPPLIER?